Ghent University Academic Bibliography

Advanced

In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model

Ingrid Burvenich, Steve Schoonooghe UGent, Bart Cornelissen, PETER BLANCKAERT UGent, Elisabeth Coene UGent, Claude Cuvelier, Nico Mertens UGent and Guido Slegers UGent (2005) CLINICAL CANCER RESEARCH. 11(20). p.7288-7296
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
CLINICAL CANCER RESEARCH
Clin. Cancer Res.
volume
11
issue
20
pages
7288-7296 pages
publisher
AMER ASSOC CANCER RESEARCH
Web of Science type
Article
Web of Science id
000232739200012
JCR category
ONCOLOGY
JCR impact factor
5.715 (2005)
JCR rank
15/123 (2005)
JCR quartile
1 (2005)
ISSN
1078-0432
DOI
10.1158/1078-0432.CCR-04-2503
language
English
UGent publication?
yes
classification
A1
id
364046
handle
http://hdl.handle.net/1854/LU-364046
date created
2005-11-09 14:21:00
date last changed
2016-12-19 15:44:32
@article{364046,
  author       = {Burvenich, Ingrid and Schoonooghe, Steve and Cornelissen, Bart and BLANCKAERT, PETER and Coene, Elisabeth and Cuvelier, Claude and Mertens, Nico and Slegers, Guido},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  language     = {eng},
  number       = {20},
  pages        = {7288--7296},
  publisher    = {AMER ASSOC CANCER RESEARCH},
  title        = {In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model},
  url          = {http://dx.doi.org/10.1158/1078-0432.CCR-04-2503},
  volume       = {11},
  year         = {2005},
}

Chicago
Burvenich, Ingrid, Steve Schoonooghe, Bart Cornelissen, Peter Blanckaert, Elisabeth Coene, Claude Cuvelier, Nico Mertens, and Guido Slegers. 2005. “In Vitro and in Vivo Targeting Properties of Iodine-123- or Iodine-131-labeled Monoclonal Antibody 14C5 in a Non-small Cell Lung Cancer and Colon Carcinoma Model.” Clinical Cancer Research 11 (20): 7288–7296.
APA
Burvenich, Ingrid, Schoonooghe, S., Cornelissen, B., Blanckaert, P., Coene, E., Cuvelier, C., Mertens, N., et al. (2005). In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. CLINICAL CANCER RESEARCH, 11(20), 7288–7296.
Vancouver
1.
Burvenich I, Schoonooghe S, Cornelissen B, Blanckaert P, Coene E, Cuvelier C, et al. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2005;11(20):7288–96.
MLA
Burvenich, Ingrid, Steve Schoonooghe, Bart Cornelissen, et al. “In Vitro and in Vivo Targeting Properties of Iodine-123- or Iodine-131-labeled Monoclonal Antibody 14C5 in a Non-small Cell Lung Cancer and Colon Carcinoma Model.” CLINICAL CANCER RESEARCH 11.20 (2005): 7288–7296. Print.